Rocket Watch 01 - 02Dec2024This is an ideal candidate for a pump. Should happen sometime in December. Watch out.
Note: This is not a recommendation or investment advice, just a stock to watch. Do your own research.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.0812 USD
−8.66 M USD
0.00 USD
About Quoin Pharmaceuticals, Ltd.
Sector
CEO
Michael Myers
Headquarters
Ashburn
Website
Founded
1986
FIGI
BBG00D9PB2L6
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
QNRX longas you see in the chart QNRX broke through a triangle pattern. QNRS tested yesterday the pattern then closed by Doji also today opened higher than yesterday's close. this is a bullish signal and hopefully, we will see a big jump soon .all the other indicators are showing positive signals. what I hav
QNRX - Move for 10% off of $24? Based on the massive move we saw yesterday I am looking for a continuation play if not for longer term at least for the short term of intraday trading.. (Not financial Advice)
QNRX first FDA-approved treatment for Netherton SyndromeQuoin Pharmaceuticals (NASDAQ: QNRX ) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide.
This month, QNRX Signed Multiple Exclusive Distribution Agreements for in various regions of the globe fo
QNRX Market Outperform Price Target !!Yesterday, JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. (QNRX) with a Market Outperform rating and a price target of 8usd.
Quoin Pharmaceuticals (NASDAQ: QNRX) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects
Quoin Pharmaceuticals also breaks the floor. QNRXAnd has been doing so in succession for some time. Looking for zigzag completion here. We just love small caps here for their phenomenal volatility.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highligh
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.